Tag: Pharma
Pharma PLI scheme to have export generation potential of Rs 1,96,000...
The scheme estimated to generate 20,000 direct and 80,000 indirect jobs, incentivizes the manufacturing of patented drugs and other high value drugs at an incentive rate of 10% of incremental sales..........................
Emcure Pharma strengthens its board
The company aims to further augment its strengths as one of the fastest growing pharmaceutical companies in India with a global reach of over 70 countries across the world..........................
Agilent hosts first virtual ‘Total Agilent Experience’ in India
Annual scientific symposium showcased Agilent’s latest analytical solutions and provided a forum to network with Agilent technical teams..........................
AstraZeneca partners with Docon to digitize healthcare clinics across India
Through this partnership AstraZeneca and Docon plans to digitize 1,000 clinics in 2021, to provide better patient outcomes for 10 Lakh patients across India..........................
Aragen expands discovery research agreement with Boehringer Ingelheim
The partnership also allows for the integrated up-scaling of compounds for larger pre-clinical studies.......................
Doceree closes Pre-Series A funding round
Company secures additional capital to accelerate product development and global expansion..................
IIHMR University’s Pharma Conclave 2021: Experts discuss next level innovations
Leading experts from India discussed the way forward in Genomics, Gene Editing, Artificial Intelligence, and Understanding the Biology of Ageing at the conclave...........................
Bayer & Zydus extend their joint venture by 3 years
Bayer Zydus Pharma will continue to operate in therapies including cardiology, diabetes, women’s health, ophthalmology and oncology, with new products in the pipeline.......................
“IQVIA offers a custom-built delivery model for biotech industry”
This edition of Chat with BioVoice features Suneela Thatte, Vice President & Head, R & D Solutions, IQVIA India who believes that the demand for faster and better drug development brought on by the pandemic is only going to accelerate the adoption of digital technologies........................
COVAXIN pricing based on many factors, says Bharat Biotech as it...
It is emblematic that Bharat Biotech has not sought Indemnity from the Government of India for any adverse events from COVAXIN...................